Immunotherapy-linked Hypoparathyroidism Shows Need to Monitor Calcium
The case of a 71-year-old man with hypoparathyroidism and low calcium that was induced by the cancer immunotherapy Keytruda (pembrolizumab) was described in a recent study. This is the third reported instance of Keytruda-induced hypoparathyroidism, highlighting…